Organ Preservation Solution Market is expected to reach US$ 399,497.49 million by 2028.

Publisher: The Insight Partners

University of Wisconsin Solution (UW) Segment Held Largest Share of Organ Preservation Solution Market

According to our new research study on "Organ Preservation Solution Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, Organ Type, and End User," the market was valued at US$ 255,917.42 million in 2022 and is expected to reach US$ 399,497.49 million by 2028; it is estimated to register a CAGR of 7.8% from 2023 to 2028.

Organ preservation solutions are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed from the human body. Organ conservation plans are implemented to save and maintain the value of organs for future applications such as transplantation and research. The development of organ preservation technologies is expected to be fueled by growing interest in organ transplantation procedures across the globe. Similarly, developing mechanically propelled techniques for saving organs support the market growth for organ preservation solutions.

Lucrative Regions for Organ Preservation Solution Market

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPHE100001100

Based on type, the organ preservation solution market is segmented into University of Wisconsin solution (UW), custodiol HTK, perfadex, hypothermosol, and others. The University of Wisconsin solution segment accounted for the largest market share in 2022. However, the hypothermosol segment is expected to record the highest CAGR of the organ preservation solution market during the forecast period. The University of Wisconsin solution segment is growing due to the solution's increased usage and several benefits. In comparison to previous treatments, the solution enables the preservation of human liver transplants for more than 15 hours. Additionally, it enables the safe transfer of organs across long distances. It is primarily used to preserve the liver and aids in enhancing the success percentage of liver transplantation. Apart from the advent of cyclosporine, one of the most significant elements in the history of liver transplantation has been the development of preservation solutions, particularly UW. Additionally, the University of Wisconsin (UW) solution is the most commonly used cold storage solution, which has increased early pancreas graft function and decreased the incidence of preservation pancreatitis. Although other preservation techniques have been developed, UW continues to be the most widely used solution for abdominal organ preservation. Increased liver transplantation is expected to drive the segment growth and contribute to the organ preservation solution market growth.

Impact of COVID-19 Pandemic on Organ Preservation Solution Market

During the COVID-19 outbreak, the demand for organ preservation solutions was reduced as healthcare settings were focused on saving lives and conducting the maximum number of tests to increase diagnosis and manage the disease. The COVID-19 pandemic was causing massive disruptions in global supply chains, consumer markets, and the economy. To avoid the risk of infection, organ donations and transplant procedures were reduced as these procedures compromise the immunity of patients. Additionally, the production of organ preservation solutions is hampered due to the shutdown of manufacturing units by the policies implemented by governments of various countries to prevent the spread of SARS-CoV-2. In 2021, the launch of vaccines led to the relaxation of preventive policies, which led to an increase in the number of surgical procedures. As a result, the market has experienced a sudden recovery. Therefore, the COVID-19 pandemic had a negative impact on the growth of the organ preservation solution market.

Waters Medical Systems LLC; XVIVO Perfusion; TransMedics; OrganOx Limited Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST CENTURY MEDICINE, Shanghai Genext Pharmaceutical Technology, and Bridge, Perfusion Solutions, Inc., Lifeline Scientific, to Life Ltd are among the leading companies operating in the organ preservation solution market.

The report segments the organ preservation solution market as follows:

The global organ preservation solution market is segmented on the basis of type, application, organ type, and end user. Based on type, the market is classified into University of Wisconsin solution (UW), custodiol HTK, perfadex, hypothermosol, and others. Based on application, the market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. Based on organ type, the market is segmented into kidney, liver, lung, heart, and others. Based on end user, the market is segmented into organ transplant centers, hospitals, and specialty clinics.

Based on geography, the organ preservation solution market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com